Among the new themes are cardiovascular system drugs, insulins, anti-parkinson drugs and thyroid hormones.
A new methodology sheds new light on the data from a more patient-centred point of view, referred to as the "insured-consumer" in our analyses.
For ease of navigation, the different themes studied are now classified by major medication classes.
We remain at your disposal for any suggestion, question or reflection on this subject.
appropriatecare@riziv-inami.fgov.be